First clinical experience with the surpass elite flow diverter in the treatment of intracranial aneurysms
Om H. Gandhi, Sami Almasri, Warda Ahmed, Suraj R. Dumasia, Nathan Yu, Mohammad S. Rashad, Linda J. Bagley, Matthew Fiesta, Omar A. Choudhri · 2026
Read First clinical experience with the surpass elite flow diverter in the treatment of intracranial aneurysms by Om H. Gandhi, Sami Almasri, Warda Ahmed, Suraj R. Dumasia, Nathan Yu, Mohammad S. Rashad, Linda J. Bagley, Matthew Fiesta, Omar A. Choudhri (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13323425.txt.
Description
Om Gandhi and eight co-authors report the first clinical use of a new brain device in a 2026 paper. The device is a mesh tube that diverts blood flow away from a weak spot in a brain artery. Such weak spots, called aneurysms, can burst and cause grave harm. The new model has a reshaped braid and a surface treatment to cut clotting.
Records cover eighty one aneurysms in seventy eight patients at four centers. Two operators placed all the devices in the first half of 2025. Every placement worked, whatever the access route used. Most aneurysms sat in the large artery that feeds the front of the brain. At about six months, most checked aneurysms had closed off fully. The authors call the early safety record sound, with more follow up to come.
Catalog record
| CREATOR | Om H. Gandhi, Sami Almasri, Warda Ahmed, Suraj R. Dumasia, Nathan Yu, Mohammad S. Rashad, Linda J. Bagley, Matthew Fiesta, Omar A. Choudhri |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 74 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |